Literature DB >> 32211108

Clear cell chondrosarcoma of the talus in Von Hippel-Lindau disease: a rare tumor in an unusual location and uncommon co-presentation.

Min Jeong Song1, Kyu Yeoun Won1, Soonchan Park2.   

Abstract

Von Hippel-Lindau (VHL) disease is an autosomal dominant inherited tumor syndrome. Clear cell chondrosarcoma (CCCS) is a rare variant of chondrosarcoma. Here, we report a case of CCCS in the talus occurring in a patient with VHL disease. A 32-year-old man presented with ankle pain for 2 years. MRI revealed a 4.2 cm mass in the talus, and needle biopsy was performed. The patient underwent curettage but the final diagnosis was CCCS. Adjuvant radiation therapy was performed without additional talectomy and the patient was alive without recurrence for a follow-up period of 2 years. To our knowledge, this is the first case in the English medical literature of a co-presentation of this rare disease and condition: i.e. CCCS with VHL disease in the unusual location of the talus. We cautiously suggest that CCCS may be associated with VHL disease based on their histologic similarity. IJCEP
Copyright © 2020.

Entities:  

Keywords:  Clear cell chondrosarcoma; Von Hippel-Lindau disease; talus

Year:  2020        PMID: 32211108      PMCID: PMC7061794     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  14 in total

1.  Clear cell chondrosarcoma of bone. A report of 8 cases.

Authors:  D Present; P Bacchini; G Pignatti; P Picci; F Bertoni; M Campanacci
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

2.  Cytogenetic findings in clear cell chondrosarcoma.

Authors:  Jun Nishio; John D Reith; Akira Ogose; Gary Maale; James R Neff; Julia A Bridge
Journal:  Cancer Genet Cytogenet       Date:  2005-10-01

3.  Comparison of next-generation sequencing mutation profiling with BRAF and IDH1 mutation-specific immunohistochemistry.

Authors:  Kausar J Jabbar; Rajalakshmi Luthra; Keyur P Patel; Rajesh R Singh; Rashmi Goswami; Ken D Aldape; L Jeffrey Medeiros; Mark J Routbort
Journal:  Am J Surg Pathol       Date:  2015-04       Impact factor: 6.394

4.  Chondrosarcoma: clear-cell variant. A report of sixteen cases.

Authors:  K K Unni; D C Dahlin; J W Beabout; F H Sim
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

5.  A genetic register for von Hippel-Lindau disease.

Authors:  I R Maddock; A Moran; E R Maher; M D Teare; A Norman; S J Payne; R Whitehouse; C Dodd; M Lavin; N Hartley; M Super; D G Evans
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

6.  An institutional review of clear cell chondrosarcoma.

Authors:  Ari Itälä; Taninnit Leerapun; Carrie Inwards; Mark Collins; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2005-11       Impact factor: 4.176

7.  Clear cell chondrosarcoma of bone. Observations in 47 cases.

Authors:  J Bjornsson; K K Unni; D C Dahlin; J W Beabout; F H Sim
Journal:  Am J Surg Pathol       Date:  1984-03       Impact factor: 6.394

8.  Clear cell chondrosarcomas arising from rare sites.

Authors:  A Ogose; T Motoyama; T Hotta; I Emura; Y Inoue; T Morita; H Watanabe
Journal:  Pathol Int       Date:  1995-09       Impact factor: 2.534

Review 9.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma.

Authors:  Danielle Meijer; Danielle de Jong; Twinkal C Pansuriya; Brendy E van den Akker; Piero Picci; Karoly Szuhai; Judith V G M Bovée
Journal:  Genes Chromosomes Cancer       Date:  2012-06-04       Impact factor: 4.263

View more
  1 in total

Review 1.  Metabolic Pathways and Targets in Chondrosarcoma.

Authors:  Ida Micaily; Megan Roche; Mohammad Y Ibrahim; Ubaldo Martinez-Outschoorn; Atrayee Basu Mallick
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.